Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

DisProt in 2022, improved quality and accessibility of protein intrinsic disorder annotation

  • Quaglia, Federica|||0000-0002-0341-4888
  • Mészáros, Bálint|||0000-0003-0919-4449
  • Salladini, Edoardo|||0000-0002-5152-5953
  • Hatos, András|||0000-0001-9224-9820
  • Pancsa, Rita|||0000-0003-0849-9312
  • Chemes, Lucía Beatriz|||0000-0003-0192-9906
  • Pajkos, Mátyás|||0000-0001-5791-9825
  • Lazar, Tamas|||0000-0001-7496-6711
  • Peña Díaz, Samuel|||0000-0002-2902-823X
  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Ács, Veronika|||0000-0001-6260-7287
  • Farahi, Nazanin|||0000-0002-6834-8578
  • Fichó, Erzsébet|||0000-0002-3965-8438
  • Aspromonte, Maria Cristina|||0000-0002-4937-6952
  • Bassot, Claudio|||0000-0001-7161-9028
  • Chasapi, Anastasia|||0000-0003-1986-5007
  • Davey, Norman E.|||0000-0001-6988-4850
  • Davidović, Radoslav|||0000-0002-6097-6203
  • Dobson, Laszlo|||0000-0003-2765-3872
  • Elofsson, Arne|||0000-0002-7115-9751
  • Erdős, Gábor|||0000-0001-6218-5192
  • Gaudet, Pascale|||0000-0003-1813-6857
  • Giglio, Michelle|||0000-0001-7628-5565
  • Glavina, Juliana|||0000-0001-6336-1290
  • Iserte, Javier|||0000-0003-0056-1177
  • Iglesias, Valentin|||0000-0002-6133-0869
  • Kálmán, Zsófia|||0000-0003-4634-0433
  • Lambrughi, Matteo|||0000-0002-0894-8627
  • Leonardi, Emanuela|||0000-0001-8486-8461
  • Longhi, Sonia|||0000-0002-6829-6771
  • Macedo-Ribeiro, Sandra|||0000-0002-7698-1170
  • Maiani, Emiliano|||0000-0003-1432-5394
  • Marchetti, Julia|||0000-0002-2886-3647
  • Marino-Buslje, Cristina|||0000-0002-6564-1920
  • Mészáros, Attila|||0000-0002-4578-4879
  • Monzon, Alexander Miguel|||0000-0003-0362-8218
  • Minervini, Giovanni|||0000-0001-7013-5785
  • Nadendla, Suvarna|||0000-0003-3643-281X
  • Nilsson, Juliet F.|||0000-0003-4203-5263
  • Novotný, Marian|||0000-0001-8788-3202
  • Ouzounis, Christos|||0000-0002-0086-8657
  • Palopoli, Nicolás|||0000-0001-7925-6436
  • Papaleo, Elena|||0000-0002-7376-5894
  • Pereira, Pedro José Barbosa|||0000-0003-0969-5438
  • Pozzati, Gabriele|||0000-0002-4303-9939
  • Promponas, Vasilis J.|||0000-0003-3352-4831
  • Pujols Pujol, Jordi|||0000-0001-9424-5866
  • Sanchez Rocha, Alma Carolina|||0000-0001-7395-9173
  • Salas, Martin|||0000-0001-6352-1282
  • Sawicki, Luciana Rodriguez|||0000-0001-5782-6573
  • Schad, Eva|||0000-0002-3006-2910
  • Shenoy, Aditi|||0000-0001-7748-2501
  • Szaniszló, Tamás|||0000-0002-3130-9284
  • Tsirigos, Konstantinos D.|||0000-0001-5280-1107
  • Veljkovic, Nevena|||0000-0001-6562-5800
  • Parisi, Gustavo|||0000-0001-7444-1624
  • Ventura, Salvador|||0000-0002-9652-6351
  • Dosztányi, Zsuzsanna|||0000-0002-3624-5937
  • Tompa, Peter|||0000-0001-8042-9939
  • Tosatto, Silvio|||0000-0003-4525-7793
  • Piovesan, Damiano|||0000-0001-8210-2390
The Database of Intrinsically Disordered Proteins (DisProt, URL: ) is the major repository of manually curated annotations of intrinsically disordered proteins and regions from the literature. We report here recent updates of DisProt version 9, including a restyled web interface, refactored Intrinsically Disordered Proteins Ontology (IDPO), improvements in the curation process and significant content growth of around 30%. Higher quality and consistency of annotations is provided by a newly implemented reviewing process and training of curators. The increased curation capacity is fostered by the integration of DisProt with APICURON, a dedicated resource for the proper attribution and recognition of biocuration efforts. Better interoperability is provided through the adoption of the Minimum Information About Disorder (MIADE) standard, an active collaboration with the Gene Ontology (GO) and Evidence and Conclusion Ontology (ECO) consortia and the support of the ELIXIR infrastructure.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

aSynPEP-DB, a database of biogenic peptides for inhibiting α-synuclein aggregation

  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Bárcenas, Oriol|||0000-0002-8439-4005
  • Iglesias, Valentin|||0000-0002-6133-0869
  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Manglano-Artuñedo, Zoe
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Burdukiewicz, Michał|||0000-0001-8926-582X
  • Ventura, Salvador|||0000-0002-9652-6351
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder, yet effective treatments able to stop or delay disease progression remain elusive. The aggregation of a presynaptic protein, α-synuclein (aSyn), is the primary neurological hallmark of PD and, thus, a promising target for therapeutic intervention. However, the lack of consensus on the molecular properties required to specifically bind the toxic species formed during aSyn aggregation has hindered the development of therapeutic molecules. Recently, we defined and experimentally validated a peptide architecture that demonstrated high affinity and selectivity in binding to aSyn toxic oligomers and fibrils, effectively preventing aSyn pathogenic aggregation. Human peptides with such properties may have neuroprotective activities and hold a huge therapeutic interest. Driven by this idea, here, we developed a discriminative algorithm for the screening of human endogenous neuropeptides, antimicrobial peptides and diet-derived bioactive peptides with the potential to inhibit aSyn aggregation. We identified over 100 unique biogenic peptide candidates and ensembled a comprehensive database (aSynPEP-DB) that collects their physicochemical features, source datasets and additional therapeutic-relevant information, including their sites of expression and associated pathways. Besides, we provide access to the discriminative algorithm to extend its application to the screening of artificial peptides or new peptide datasets. aSynPEP-DB is a unique repository of peptides with the potential to modulate aSyn aggregation, serving as a platform for the identification of previously unexplored therapeutic agents. Database URL:.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A3D Model Organism Database (A3D-MODB), a database for proteome aggregation predictions in model organisms

  • Badaczewska-Dawid, Aleksandra E.
  • Kuriata, Aleksander
  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Garcia-Pardo, Javier|||0000-0001-9179-6371
  • Burdukiewicz, Michał|||0000-0001-8926-582X
  • Iglesias, Valentin|||0000-0002-6133-0869
  • Kmiecik, Sebastian|||0000-0001-7623-0935
  • Ventura, Salvador|||0000-0002-9652-6351
Protein aggregation has been associated with aging and different pathologies and represents a bottleneck in the industrial production of biotherapeutics. Numerous past studies performed in Escherichia coli and other model organisms have allowed to dissect the biophysical principles underlying this process. This knowledge fuelled the development of computational tools, such as Aggrescan 3D (A3D) to forecast and re-design protein aggregation. Here, we present the A3D Model Organism Database (A3D-MODB) , a comprehensive resource for the study of structural protein aggregation in the proteomes of 12 key model species spanning distant biological clades. In addition to A3D predictions, this resource incorporates information useful for contextualizing protein aggregation, including membrane protein topology and structural model confidence, as an indirect reporter of protein disorder. The database is openly accessible without any need for registration. We foresee A3D-MOBD evolving into a central hub for conducting comprehensive, multi-species analyses of protein aggregation, fostering the development of protein-based solutions for medical, biotechnological, agricultural and industrial applications.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Pathogen-specific structural features of Candida albicans Ras1 activation complex: uncovering new antifungal drug targets

  • Manso, José A.
  • Carabias, Arturo
  • Sárkány, Zsuzsa
  • Pereda, José M. de
  • Barbosa Pereira, Pedro José
  • Macedo-Ribeiro, Sandra
An important feature associated with Candida albicans pathogenicity is its ability to switch between yeast and hyphal forms, a process in which CaRas1 plays a key role. CaRas1 is activated by the guanine nucleotide exchange factor (GEF) CaCdc25, triggering hyphal growth-related signaling pathways through its conserved GTP-binding (G)-domain. An important function in hyphal growth has also been proposed for the long hypervariable region downstream the G-domain, whose unusual content of polyglutamine stretches and Q/N repeats make CaRas1 unique within Ras proteins. Despite its biological importance, both the structure of CaRas1 and the molecular basis of its activation by CaCdc25 remain unexplored. Here, we show that CaRas1 has an elongated shape and limited conformational flexibility and that its hypervariable region contains helical structural elements, likely forming an intramolecular coiled-coil. Functional assays disclosed that CaRas1-activation by CaCdc25 is highly efficient, with activities up to 2,000-fold higher than reported for human GEFs. The crystal structure of the CaCdc25 catalytic region revealed an active conformation for the ¿-helical hairpin, critical for CaRas1-activation, unveiling a specific region exclusive to CTG-clade species. Structural studies on CaRas1/CaCdc25 complexes also revealed an interaction surface clearly distinct from that of homologous human complexes. Furthermore, we identified an inhibitory synthetic peptide, prompting the proposal of a key regulatory mechanism for CaCdc25. To our knowledge, this is the first report of specific inhibition of the CaRas1-activation via targeting its GEF. This, together with their unique pathogen-structural features, disclose a set of novel strategies to specifically block this important virulence-related mechanism., This work was funded by the European Union’s Horizon 2020 Research and Innovation programme under grant agreement ID 952334 “PhasAGE” and by Portuguese funds through Fundação para a Ciência e a Tecnologia (FCT) in the framework of project 2022.05176.PTDC. J.A.M. also acknowledges FCT for research contracts POCI-01– 0145-FEDER-029221 and PTDC/BIA-BQM/2494/2020, Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

In-Silico Analysis of pH-Dependent Liquid-Liquid Phase Separation in Intrinsically Disordered Proteins

  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Bárcenas, Oriol|||0000-0002-8439-4005
  • Ventura, Salvador|||0000-0002-9652-6351
Intrinsically disordered proteins (IDPs) are essential players in the assembly of biomolecular condensates during liquid-liquid phase separation (LLPS). Disordered regions (IDRs) are significantly exposed to the solvent and, therefore, highly influenced by fluctuations in the microenvironment. Extrinsic factors, such as pH, modify the solubility and disorder state of IDPs, which in turn may impact the formation of liquid condensates. However, little attention has been paid to how the solution pH influences LLPS, despite knowing that this process is context-dependent. Here, we have conducted a large-scale in-silico analysis of pH-dependent solubility and disorder in IDRs known to be involved in LLPS (LLPS-DRs). We found that LLPS-DRs present maximum solubility around physiological pH, where LLPS often occurs, and identified significant differences in solubility and disorder between proteins that can phase-separate by themselves or those that require a partner. We also analyzed the effect of mutations in the resulting solubility profiles of LLPS-DRs and discussed how, as a general trend, LLPS-DRs display physicochemical properties that permit their LLPS at physiologically relevant pHs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cryo-EM structure of hnRNPDL-2 fibrils, a functional amyloid associated with limb-girdle muscular dystrophy D3

  • Garcia-Pardo, Javier|||0000-0001-9179-6371
  • Bartolomé-Nafría, Andrea|||0000-0003-3114-1415
  • Chaves-Sanjuan, Antonio|||0000-0003-3287-9024
  • Gil-Garcia, Marcos|||0000-0002-7457-7860
  • Visentin, Cristina|||0000-0003-2705-1417
  • Bolognesi, Martino|||0000-0002-9253-5170
  • Ricagno, Stefano|||0000-0001-6678-5873
  • Ventura, Salvador|||0000-0002-9652-6351
hnRNPDL is a ribonucleoprotein (RNP) involved in transcription and RNA-processing that hosts missense mutations causing limb-girdle muscular dystrophy D3 (LGMD D3). Mammalian-specific alternative splicing (AS) renders three natural isoforms, hnRNPDL-2 being predominant in humans. We present the cryo-electron microscopy structure of full-length hnRNPDL-2 amyloid fibrils, which are stable, non-toxic, and bind nucleic acids. The high-resolution amyloid core consists of a single Gly/Tyr-rich and highly hydrophilic filament containing internal water channels. The RNA binding domains are located as a solenoidal coat around the core. The architecture and activity of hnRNPDL-2 fibrils are reminiscent of functional amyloids, our results suggesting that LGMD D3 might be a loss-of-function disease associated with impaired fibrillation. Strikingly, the fibril core matches exon 6, absent in the soluble hnRNPDL-3 isoform. This provides structural evidence for AS controlling hnRNPDL assembly by precisely including/skipping an amyloid exon, a mechanism that holds the potential to generate functional diversity in RNPs. The authors report the Cryo-EM of hnRNPDL-2 fibrils. The structure highlights features of a functional amyloid associated with limb-girdle muscular dystrophy-3 and explains how alternative splicing controls the assembly of this ribonucleoprotein.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Exploring cryptic amyloidogenic regions in prion-like proteins from plants

  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Iglesias, Valentin|||0000-0002-6133-0869
  • Manglano-Artuñedo, Zoe
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Ventura, Salvador|||0000-0002-9652-6351
Prion-like domains (PrLDs) are intrinsically disordered regions (IDRs) of low sequence complexity with a similar composition to yeast prion domains. PrLDs-containing proteins have been involved in different organisms' regulatory processes. Regions of moderate amyloid propensity within IDRs have been shown to assemble autonomously into amyloid fibrils. These sequences tend to be rich in polar amino acids and often escape from the detection of classical bioinformatics screenings that look for highly aggregation-prone hydrophobic sequence stretches. We defined them as cryptic amyloidogenic regions (CARs) and recently developed an integrated database that collects thousands of predicted CARs in IDRs. CARs seem to be evolutionary conserved among disordered regions because of their potential to stablish functional contacts with other biomolecules. Here we have focused on identifying and characterizing CARs in prion-like proteins (pCARs) from plants, a lineage that has been poorly studied in comparison with other prionomes. We confirmed the intrinsic amyloid potential for a selected pCAR from Arabidopsis thaliana and explored functional enrichments and compositional bias of pCARs in plant prion-like proteins.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Development of Small Molecules Targeting α-Synuclein Aggregation, A Promising Strategy to Treat Parkinson's Disease

  • Peña Díaz, Samuel|||0000-0002-2902-823X
  • Garcia-Pardo, Javier|||0000-0001-9179-6371
  • Ventura, Salvador|||0000-0002-9652-6351
Parkinson's disease, the second most common neurodegenerative disorder worldwide, is characterized by the accumulation of protein deposits in the dopaminergic neurons. These deposits are primarily composed of aggregated forms of α-Synuclein (α-Syn). Despite the extensive research on this disease, only symptomatic treatments are currently available. However, in recent years, several compounds, mainly of an aromatic character, targeting α-Syn self-assembly and amyloid formation have been identified. These compounds, discovered by different approaches, are chemically diverse and exhibit a plethora of mechanisms of action. This work aims to provide a historical overview of the physiopathology and molecular aspects associated with Parkinson's disease and the current trends in small compound development to target α-Syn aggregation. Although these molecules are still under development, they constitute an important step toward discovering effective anti-aggregational therapies for Parkinson's disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Small molecules to target tau amyloid aggregation

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

CARs-DB, A Database of Cryptic Amyloidogenic Regions in Intrinsically Disordered Proteins

  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Vilaça, Rita
  • Macedo-Ribeiro, Sandra|||0000-0002-7698-1170
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Ventura, Salvador|||0000-0002-9652-6351
  • Bárcenas, Oriol|||0000-0002-8439-4005
  • Manglano-Artuñedo, Zoe
Proteome-wide analyses suggest that most globular proteins contain at least one amyloidogenic region, whereas these aggregation-prone segments are thought to be underrepresented in intrinsically disordered proteins (IDPs). In recent work, we reported that intrinsically disordered regions (IDRs) indeed sustain a significant amyloid load in the form of cryptic amyloidogenic regions (CARs). CARs are widespread in IDRs, but they are necessarily exposed to solvent, and thus they should be more polar and have a milder aggregation potential than conventional amyloid regions protected inside globular proteins. CARs are connected with IDPs function and, in particular, with the establishment of protein-protein interactions through their IDRs. However, their presence also appears associated with pathologies like cancer or Alzheimer's disease. Given the relevance of CARs for both IDPs function and malfunction, we developed CARs-DB, a database containing precomputed predictions for all CARs present in the IDPs deposited in the DisProt database. This web tool allows for the fast and comprehensive exploration of previously unnoticed amyloidogenic regions embedded within IDRs sequences and might turn helpful in identifying disordered interacting regions. It contains.